Comprehensive oncology journal

iCancer

Publishing rigorous cancer research across discovery, translation, clinical care, population health, and patient outcomes.

Submit or Review Editorial Office

Aim and Scope

iCancer aims to publish high-quality, peer-reviewed research that improves the understanding, diagnosis, treatment, prevention, and care of cancer. The journal welcomes studies spanning basic cancer biology, tumor microenvironment, molecular mechanisms, translational oncology, clinical trials, precision medicine, immuno-oncology, imaging, biomarkers, cancer epidemiology, survivorship, health services research, and cancer policy.

The journal prioritizes work with clear biological insight, clinical relevance, methodological rigor, transparent reporting, and potential value for researchers, clinicians, patients, and health systems.

Comprehensive oncology scope visual

Scope Areas

  • Cancer biology, genetics, epigenetics, signaling, metastasis, and tumor evolution.
  • Tumor microenvironment, immunology, immunotherapy, resistance, and host-tumor interactions.
  • Translational research, biomarkers, molecular diagnostics, pathology, imaging, and liquid biopsy.
  • Clinical oncology, therapeutic trials, surgical oncology, radiation oncology, systemic treatment, and precision medicine.
  • Cancer prevention, screening, epidemiology, survivorship, supportive care, quality of life, and patient-reported outcomes.
  • Digital oncology, artificial intelligence, real-world evidence, implementation science, and cancer care delivery.

Article Types

Original Research

Basic, translational, clinical, population, and methods studies with clear reporting and reproducible evidence.

Reviews and Perspectives

Focused reviews, systematic reviews, expert perspectives, and clinically relevant updates in oncology.

Clinical and Policy Reports

Trial reports, real-world evidence, guidelines discussion, implementation studies, and cancer care policy analyses.

Oncology article types visual
Oncology submission preparation visual

Submission Preparation

Reporting

Authors should follow relevant reporting guidelines and provide transparent methods, ethics approval, and trial registration when applicable.

Data and Materials

Data availability, code availability, and material sharing statements should be provided when relevant to the study type.

Editorial Checks

The platform is being configured to collect conflict of interest, AI disclosure, ethics, and compliance fields during submission.